Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses

Richard A. Koup, Mario Roederer, Laurie Lamoreaux et al. · 2010

Read Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses by Richard A. Koup, Mario Roederer, Laurie Lamoreaux et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009015.txt.

Description

Richard Koup and co-authors tested a two-step vaccine plan against HIV, in PLOS ONE in 2010. A vaccine must raise both antibodies and T cells tuned to HIV-1. Prime-boost plans use two different vaccine types in sequence. Earlier animal work showed such mixes can raise strong, broad T-cell responses.

The team primed with a DNA vaccine, then boosted with an adenoviral vector vaccine. The DNA first step made the boost work harder. Both antibody levels and T-cell responses against HIV-1 grew stronger. Better priming could stretch the power of vaccines that are weak alone.

Catalog record

CREATORRichard A. Koup, Mario Roederer, Laurie Lamoreaux et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE70 KB
LICENSECreative Commons CC0 License
RIGHTSCC0
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009015

Browse the full library · About the Tower of Babel